ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis"

  • Abstract Number: 0497 • ACR Convergence 2025

    Drug Survival and Discontinuation Reasons of Eight Biological Disease-Modifying Antirheumatic Drugs in 1,182 Patients with Rheumatoid Arthritis: A Retrospective Study Using the Niigata Orthopedic Rheumatoid Arthritis Database (NOSRAD)

    Nariaki Hao and Naoki Kondo, Division of Orthopedic Surgery, Niigata University Medical and Dental General Hospital, Niigata, Japan

    Background/Purpose: To retrospectively evaluate drug survival and reasons for discontinuation of eight biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA) patients using the Niigata…
  • Abstract Number: 0480 • ACR Convergence 2025

    Efficacy and safety of tacrolimus and its serum concentration in patients with rheumatoid arthritis with inadequate response to methotrexate

    Chan-Bum Choi, Hanyang University Hosptial for Rheumatic Diseases, Seoul, Republic of Korea

    Background/Purpose: Addition of a biologic disease-modifying antirheumatic drug (bDMARD) or targeted synthetic DMARD (tsDMARD) is recommended in patients with rheumatoid arthritis (RA) with inadequate response…
  • Abstract Number: 0463 • ACR Convergence 2025

    Synovial fluid is a robust biomarker of synovial tissue inflammation in rheumatoid arthritis

    Solana Cushing1, Susan Goodman2, Michael Parides1, Hadeel Abdul-Rehman1, Daniel Ramirez2, Edward DiCarlo2, Kristine Carandang3, Renee Davis4, Rebecca Blank5, Laura Donlin1, Anna Helena Jonsson6, Amit Lakhanpal2, Bella Mehta7, Dana Orange8 and Melanie smith2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 3Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA, 4New York, New York, NY, 5NYU Langone Health, New York, NY, 6University of Colorado School of Medicine, Aurora, CO, 7Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ, 8The Rockefeller University, New York, NY

    Background/Purpose: Synovial tissue pathotype may indicate treatment response in RA, but synovial biopsies are not widely available. Synovial fluid (SF) is a promising surrogate. We…
  • Abstract Number: 0447 • ACR Convergence 2025

    Foot-pressure distribution method for detection of foot joint arthritis in patients with rheumatic diseases

    Hayagrivas Manicka Bharathkumar1, Emani Srinija Reddy1, Bhaskar Pandey2, Suryansh Saini1, Sangeet Rathi1, Saransh Verma1, Chinmay Prakash Swami2, Deepak Joshi2 and Ranjan Gupta1, 1All India Institute of Medical Sciences (AIIMS), New Delhi, Delhi, Delhi, India, 2Indian Institute of Technology (IIT), Delhi, Delhi, Delhi, India

    Background/Purpose: Rheumatoid arthritis (RA) and Seronegative Spondyloarthritis (SSA), the most common types of inflammatory arthritis, have significant ankle and foot joint involvement. However, these joints…
  • Abstract Number: 0380 • ACR Convergence 2025

    Multidimensional Health Assessment Questionnaire (MDHAQ)/RAPID3, is an Useful Tool to Assess Comorbid and Residual Fatigue in Rheumatoid Arthritis Patients

    Rosa Maria Morlà Novell1, Beatriz Frade Sosa2, Maria López-Lasanta3, Meritxell Sallés Lizarzáburu4, Noemí Busquets Pérez5, Georgina Salvador Alarcón6, Marta Valls Roc7, Virginia Ruiz-Esquide8, Lola Tobalina Mastre9, Raimon Sanmartí8 and José Gomez-Puerta10, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, 3Hospital Universitari Vall d´Hebron, Barcelona, Spain, 4Xarxa Sanitària Althaia Manresa, Manresa, Spain, 5Hospital de Granollers, Granollers, Spain, 6Hospital Universitari Mùtua Terrassa, Terrassa, Spain, 7Hospital Universitari Dr Trueta, Girona, Sudan, 8Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain, 9IDIBAPS. Hospital Clinic de Barcelona, Barcelona, 10Rheumatology Department, Hospital Clinic, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: Fatigue is a highly prevalent (40%-70%)1 comorbidity in rheumatoid arthritis (RA) patients, and residual fatigue has been described in a significant proportion of patients…
  • Abstract Number: 0219 • ACR Convergence 2025

    Increased Engagement With the RISE Registry Clinician Dashboard Is Associated With Improving Performance on Some but Not All Rheumatology Quality Measures

    Jing Li1, Jessica Fitzpatrick2, Jinoos Yazdany2 and gabriela Schmajuk3, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA

    Background/Purpose: Previous studies have shown that quality measure performance tends to improve after practices join the ACR’s Rheumatology Informatics System for Effectiveness (RISE) registry, but…
  • Abstract Number: 0149 • ACR Convergence 2025

    Effect Of Osteoporosis And Opioid Use On Mortality And Unplanned Healthcare Utilization Among Patients With Rheumatoid Arthritis

    Viengneesee Thao, Molly Moore Jeffery, Nafisseh Warner and Elena myasoedova, Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) have a 2-fold increase in risk for osteoporosis compared to the general population. About 30-50% of RA patients experience…
  • Abstract Number: 0082 • ACR Convergence 2025

    IBI3011, a Humanized anti-IL1RAP Monoclonal Antibody, Inhibits IL1, IL33, IL36-driven Inflammation Pathway, and Attenuates Inflammation in Preclinical Inflammatory Disease Model

    Hongling Tian, Lidan Liang, Chenjuan Zhu, Bin Li, Lei Cao, Meng Ni, Fan Chen, Zhimin Zhang, Min Wu, Tong Liu, Jinyang Li, Yao Xiong, Li Li, Shuaixiang Zhou, Enhong Zhong and Huizhong Xiong, Innovent Biologics (Suzhou) Co., Ltd., Suzhou, Jiangsu, China (People's Republic)

    Background/Purpose: Interleukin 1 receptor accessory protein (IL1RAP) serves as a co-receptor that forms receptor complexes with IL1R1, ST2, and IL36R and mediates signaling pathways triggered…
  • Abstract Number: 0064 • ACR Convergence 2025

    Sclerostin from marrow adipogenic precursors is essential for bone and joint homeostasis in mice

    Tailin He and Yifang Mei, Shenzhen Third People's Hospital, Shenzhen, China (People's Republic)

    Background/Purpose: A novel mesenchymal subpopulation known as 'marrow adipogenic lineage precursors' (MALPs) has been identified, characterized by the expression of various adipocyte markers while lacking…
  • Abstract Number: 0006 • ACR Convergence 2025

    QEL-005: CD19 CAR-Regulatory T cell therapy, a novel approach for the treatment of complex immune mediated inflammatory diseases including Rheumatoid Arthritis and Systemic Sclerosis

    Jenny McGovern, Georgios Eleftheriadis, Thomas Grothier, Eva Bugallo Blanco, Anna Koi, Mahsa Nemani, Cameron Allum, Emily Hurley, Daniela Penston, Marc Martinez-Llordella, Luke Devey and Nathalie Belmonte, Quell Therapeutics, London, United Kingdom

    Background/Purpose: Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc) are immune mediated inflammatory diseases (IMID) where a complex interplay of tissue and immune cell activation drives…
  • Abstract Number: 2628 • ACR Convergence 2025

    Calprotectin and Anti-CCP Antibodies Predict Development of Preeclampsia

    Daniele Marcy1, Nanette Santoro2, Claudia Lugo3, Kristin Sturm2 and Kristen Demoruelle4, 1University of Colorado, Northglenn, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3University of Colorado, Denver, CO, 4University of Colorado Anschutz Medical Campus, Golden, CO

    Background/Purpose: Several systemic autoimmune diseases are associated with an increased risk of preeclampsia. Preeclampsia is a pregnancy complication characterized by new-onset hypertension after 20 weeks…
  • Abstract Number: 2289 • ACR Convergence 2025

    Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Disease Activity in Patients with Rheumatoid Arthritis: A Pilot Study

    Yuichiro Fujieda1, Kaoru Murakami2, Hiroki Tanaka2, Yuichi Kojima2, Yuki Kudo1, Kohei Karino1, Hiroyuki Nakamura1, Ryo Hisada1, Michihito Kono1, Masaaki Murakami2 and Tatsuya Atsumi1, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, 2Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    Background/Purpose: Vagus nerve stimulation (VNS) has emerged as a potential therapeutic strategy for inflammatory diseases by modulating inflammatory reflex pathways. Transcutaneous auricular vagus nerve stimulation…
  • Abstract Number: 2271 • ACR Convergence 2025

    Assessing the Real-World Impact of Earlier Initiation of Adalimumab vs. Conventional Synthetic DMARDs on Healthcare Resource Utilization in Patients with Rheumatoid Arthritis in Europe

    Daniel Aletaha1, Dr. Carmen Bremer2, Jack Milligan3, Zichun Cao4, Rachael Meadows3 and Xenofon Baraliakos5, 1Medical University Vienna, Wien, Austria, 2Sandoz International GmbH, Holzkirchen, Germany, 3Adelphi Real World, Macclesfield, United Kingdom, 4Sandoz Incorporated, Princeton, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Early use of targeted therapy (TT), such as anti-tumor necrosis factor (anti-TNF) biologics, show improved outcomes for RA1, but costs often limit access. Biosimilars,…
  • Abstract Number: 2255 • ACR Convergence 2025

    Diagnostic Accuracy of Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis: A Systematic Review and Meta-analysis

    Pannathorn Nakaphan1, Patavee Pajareya2, Priabprat Jansem3, Somkiat Phutinart2, Nattanicha Chaisrimaneepan4 and Noppachai Siranart2, 1Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, 2Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, 3Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand, 4Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose: Anti-carbamylated protein antibodies (anti-CarP Ab) are emerging serologic markers in rheumatoid arthritis (RA). Anti-CarP Ab has a controversial diagnostic utility in RA but may…
  • Abstract Number: 2238 • ACR Convergence 2025

    Impact of Type 2 Diabetes on Cardiovascular and Renal Outcomes in Rheumatoid Arthritis: Insights from a Large-Scale Multi-Center Analysis

    Godbless Ajenaghughrure1, Sila Mateo Faxas2, Gurjot Singh3, Nirys Mateo Faxas4, Kim Nguyen3, Nicole Tejeda5 and Kimberly Ramirez Bonetti6, 1Trihealth Good Samaritan Hospital, Cincinnati, OH, 2Good Samaritan Hospital, Cincinnati, OH, 3Trihealth Good Samaritan Hospital, Cincinnati, 4Independent Author, Santo Domingo, Dominican Republic, 5Independent Author, Cincinnati, 6Independent Author, cincinnati, OH

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased cardiovascular risk, but the additional impact of type 2 diabetes mellitus (T2DM) on the cardiorenal outcomes in…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 219
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology